CTOs on the Move

Iota Biosciences

www.iota.bio

 
Established in 2017, iota Biosciences was formed with a vision to change how the world monitors and treats disease. Building on award-winning `neural-dust` technology invented at the University of California, Berkeley, we are building a platform for the future of bioelectronic medicine.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.iota.bio
  • 1936 University Ave
    Berkeley, CA USA
  • Phone: 888.666.O576

Executives

Name Title Contact Details

Funding

Iota Biosciences raised $15M on 12/27/2018

Similar Companies

Cayenne Medical

Cayenne Medical is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Canadian Medical Products

Canadian Medical Products is a Scarborough, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Radius Medical

Radius Medical is a Acton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Brijjitco

The Brijjit™ technology is created and produced by BrijjitCo, a limited liability company based in Atlanta, GA.. Our founder and CEO, Felmont (Monte) F. Eaves, III, MD, FACS, is a highly credentialed plastic surgeon who saw a gap and was determined to bridge it. No, we`re not a huge company. Yet. But we are singularly focused on improving the surgical landscape with breakthrough technologies that will support surgeons everywhere in their goal to deliver the most spectacular outcomes. We strongly believe that Brijjit™ is just such an innovation, and we don`t plan to stop there!

RenalGuard Solutions

Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.